KSR2
Kinase suppressor of Ras 2
Also known as: FLJ25965, KSR2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6VAB6
- Gene
- KSR2
- Ensembl
- ENSG00000171435
- Chromosome
- 12
- Canonical length
- 950 aa
- Protein class
- Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins
OverviewNCBI Gene
Enables protein serine/threonine kinase activity. Predicted to be involved in Ras protein signal transduction; calcium-mediated signaling; and positive regulation of cold-induced thermogenesis. Predicted to act upstream of or within positive regulation of MAPK cascade. Predicted to be located in membrane. Predicted to be active in cytosol and plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
950 residues, UniProt reviewed canonical sequence.
>Q6VAB6|KSR2
1 MDEENMTKSE EQQPLSLQKA LQQCELVQNM IDLSISNLEG LRTKCATSND LTQKEIRTLE
61 SKLVKYFSRQ LSCKKKVALQ ERNAELDGFP QLRHWFRIVD VRKEVLEEIS PGQLSLEDLL
121 EMTDEQVCET VEKYGANREE CARLNASLSC LRNVHMSGGN LSKQDWTIQW PTTETGKENN
181 PVCPPEPTPW IRTHLSQSPR VPSKCVQHYC HTSPTPGAPV YTHVDRLTVD AYPGLCPPPP
241 LESGHRSLPP SPRQRHAVRT PPRTPNIVTT VTPPGTPPMR KKNKLKPPGT PPPSSRKLIH
301 LIPGFTALHR SKSHEFQLGH RVDEAHTPKA KKKSKPLNLK IHSSVGSCEN IPSQQRSPLL
361 SERSLRSFFV GHAPFLPSTP PVHTEANFSA NTLSVPRWSP QIPRRDLGNS IKHRFSTKYW
421 MSQTCTVCGK GMLFGLKCKN CKLKCHNKCT KEAPPCHLLI IHRGDPARLV RTESVPCDIN
481 NPLRKPPRYS DLHISQTLPK TNKINKDHIP VPYQPDSSSN PSSTTSSTPS SPAPPLPPSA
541 TPPSPLHPSP QCTRQQKNFN LPASHYYKYK QQFIFPDVVP VPETPTRAPQ VILHPVTSNP
601 ILEGNPLLQI EVEPTSENEE VHDEAEESED DFEEMNLSLL SARSFPRKAS QTSIFLQEWD
661 IPFEQLEIGE LIGKGRFGQV YHGRWHGEVA IRLIDIERDN EDQLKAFKRE VMAYRQTRHE
721 NVVLFMGACM SPPHLAIITS LCKGRTLYSV VRDAKIVLDV NKTRQIAQEI VKGMGYLHAK
781 GILHKDLKSK NVFYDNGKVV ITDFGLFSIS GVLQAGRRED KLRIQNGWLC HLAPEIIRQL
841 SPDTEEDKLP FSKHSDVFAL GTIWYELHAR EWPFKTQPAE AIIWQMGTGM KPNLSQIGMG
901 KEISDILLFC WAFEQEERPT FTKLMDMLEK LPKRNRRLSH PGHFWKSAELLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KSR2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 7.4 nTPM
Expression across tissuesHPA
Tissue
- pituitary gland: 7.4 nTPM
- cerebellum: 5.4 nTPM
- cerebral cortex: 3 nTPM
- basal ganglia: 2.5 nTPM
- hippocampal formation: 2.1 nTPM
- hypothalamus: 1.9 nTPM
Single-cell type
- lactotrophs: 1,078 nCPM
- thyrotrophs: 906 nCPM
- somatotrophs: 887 nCPM
- renal collecting duct principal cells: 737 nCPM
- gonadotrophs: 642 nCPM
- corticotrophs: 532 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 44 nTPM
- hippocampal formation: 39 nTPM
- white matter: 29 nTPM
- basal ganglia: 28 nTPM
- cerebellum: 24 nTPM
- hypothalamus: 23 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about KSR2.
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 431 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- KSR2-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.13
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.34
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- calcium-mediated signaling
- positive regulation of cold-induced thermogenesis
- positive regulation of MAPK cascade
- Ras protein signal transduction
Molecular functions
- ATP binding
- MAP-kinase scaffold activity
- mitogen-activated protein kinase kinase binding
- protein kinase activity
- protein serine kinase activity
- protein serine/threonine kinase activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- Serine-threonine/tyrosine-protein kinase, catalytic domain
- Protein kinase C-like, phorbol ester/diacylglycerol-binding domain
- Serine/threonine-protein kinase, active site
- Protein kinase-like domain superfamily
- Sterile alpha motif/pointed domain superfamily
- C1-like domain superfamily
- Kinase suppressor RAS 1, N-terminal helical hairpin
- Kinase suppressor RAS 1, N-terminal helical hairpin superfamily
- Serine/threonine-protein kinase
- Protein tyrosine and serine/threonine kinase
- Kinase suppressor RAS 1 N-terminal helical hairpin
- Kinase suppressor of RAS, SAM-like domain
- SAM like domain present in kinase suppressor RAS 1
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KSR2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KSR2 as an antibody target. Whether an autoantibody or antibody against KSR2 could matter depends on whether native KSR2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KSR2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label KSR2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...